Renal angiotensin II type 1 receptor expression and associated hypertension in rats with minimal SHR nuclear genome

Physiological Reports

Volumn 1, Issue 5, 2013, Pages

  Collett, Jason A ^a   Hart, Anne K ^b   Patterson, Elaine ^c   Kretzer, Julie ^c   Osborn, Jeffrey L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angiotensin receptors; Genetic hypertension; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE PROTEIN; MESSENGER RNA; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BORDERLINE HYPERTENSION; BROWN NORWAY RAT; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA EXTRACTION; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

EID: 85009154424     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.104     Document Type: Article

References (50)

1. Baudin, B. 2002. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics 3: 65–73.
2. Benigni, A., D. Corna, C. Zoja, A. Sonzogni, R. Latini, M. Salio, et al. 2009. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 119: 524–530.
3. Bonnardeaux, A., E. Davies, X. Jeunemaitre, I. Fery, A. Charru, E. Clauser, et al. 1994. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24: 63–69.
4. Carey, R. M., and H. M. Siragy. 2003. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 24: 261–271.
5. de Cavanagh, E. M. V., J. E. Toblli, L. Ferder, B. Piotrkowski, I. Stella, and F. Inserra. 2006. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R1616–R1625.
6. Chan, S. H., K. L. Wu, A. Y. Chang, M. H. Tai, and J. Y. Chan. 2009. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 53: 217–227.
7. Cowley, A. W., Jr. 1992. Long-term control of arterial blood pressure. Physiol. Rev. 72: 231–300.
8. Deng, A. Y., H. Dene, and J. P. Rapp. 1994. Mapping of a quantitative trait locus for blood pressure on rat chromosome 2. J. Clin. Invest. 94: 431–436.
9. Doris, P. A. 2002. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 39: 323–331.
10. de Gasparo, M., K. J. Catt, T. Inagami, J. W. Wright, and T. Unger. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52: 415–472.
11. Gyurko, R., D. Wielbo, and M. I. Phillips. 1993. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49: 167–174.
12. Herrera, M., M. A. Sparks, A. R. Alfonso-Pecchio, L. M. Harrison-Bernard, and T. M. Coffman. 2013. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension 61: 253–258.
13. Hilbert, P., K. Lindpaintner, J. S. Beckmann, T. Serikawa, F. Soubrier, C. Dubay, et al. 1991. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353: 521–529.
14. Hopkins, P. N., and S. C. Hunt. 2003. Genetics of hypertension. Genet. Med. 5: 413–429.
15. Jeunemaitre, X., F. Soubrier, Y. V. Kotelevtsev, R. P. Lifton, C. S. Williams, A. Charru, et al. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169–180.
16. Joe, B., and M. Garrett. 2005. Substitution mapping. Pp. 41–58 in M. Rai, J. R. Paton, S. Kasparov, and M. Katovich, eds. Cardiovascular genomics. Humana Press Inc., Totowa, NJ.
17. Kainulainen, K., M. Perola, J. Terwilliger, J. Kaprio, M. Koskenvuo, A. C. Syvanen, et al. 1999. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33: 844–849.
18. Kaschina, E., and T. Unger. 2003. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 12: 70–88.
19. Kumarasamy, S., K. Gopalakrishnan, A. Shafton, J. Nixon, J. Thangavel, P. Farms, et al. 2010. Mitochondrial polymorphisms in rat genetic models of hypertension. Mamm. Genome 21: 299–306.
20. Kurtz, T. W., K. A. Griffin, A. K. Bidani, R. L. Davisson, and J. E. Hall. 2005. Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler. Thromb. Vasc. Biol. 25: e22–e33.
21. Kwitek-Black, A., and H. Jacob. 2001. The use of designer rats in the genetic dissection of hypertension. Curr. Hypertens. Rep. 3: 12–18.
22. Lenkei, Z., M. Palkovits, P. Corvol, and C. Llorens-Cortes. 1997. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18: 383–439.
23. Li, R., Y. Liu, Z. Li, L. Yang, S. Wang, and M. X. Guan. 2009. Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A>G mutation are involved in essential hypertension in a Han Chinese family. Hypertension 54: 329–337.
24. Lifton, R. P., A. G. Gharavi, and D. S. Geller. 2001. Molecular mechanisms of human hypertension. Cell 104: 545–556.
25. Liu, Y., R. Li, Z. Li, X. J. Wang, L. Yang, S. Wang, et al. 2009. Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree. Hypertension 53: 1083–1090.
26. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275.
27. National Heart, Lung and Blood Institute, Nihon Gaujutsu Shinkokai, National Science Foundation. 1977. Spontaneous hypertension, its pathogenesis and complications. Proceedings of the 2d International Symposium on the Spontaneously Hypertensive Rat. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, Balboa Bay Club, Newport Beach, CA, 16–18 April, 1976.
28. Norton, G. R., R. Brooksbank, and A. J. Woodiwiss. 2010. Gene variants of the renin-angiotensin system and hypertension: from a trough of disillusionment to a welcome phase of enlightenment? Clin. Sci. (Lond.) 118: 487–506.
29. Park, J. B., R. M. Touyz, X. Chen, and E. L. Schiffrin. 2002. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 15: 78–84.
30. Pinto, Y. M., M. Paul, and D. Ganten. 1998. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc. Res. 39: 77–88.
31. Pravenec, M., M. Hyakukoku, J. Houstek, V. Zidek, V. Landa, P. Mlejnek, et al. 2007. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res. 17: 1319–1326.
32. Raizada, M. K., C. Sumners, and D. Lu. 1993. Angiotensin II type 1 receptor mRNA levels in the brains of normotensive and spontaneously hypertensive rats. J. Neurochem. 60: 1949–1952.
33. Rapp, J. P. 2000. Genetic analysis of inherited hypertension in the rat. Physiol. Rev. 80: 135–172.
34. Rapp, J. P., H. Dene, and A. Y. Deng. 1994. Seven renin alleles in rats and their effects on blood pressure. J. Hypertens. 12: 349–355.
35. Reinhart, G. A., T. E. Lohmeier, and C. E. Hord Jr. 1995. Hypertension induced by chronic renal adrenergic stimulation is angiotensin dependent. Hypertension 25: 940–949.
36. Reja, V., A. K. Goodchild, J. K. Phillips, and P. M. Pilowsky. 2006. Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin. Exp. Pharmacol. Physiol. 33: 690–695.
37. Rigat, B., C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86: 1343–1346.
38. Rodriguez-Iturbe, B., C. D. Zhan, Y. Quiroz, R. K. Sindhu, and N. D. Vaziri. 2003. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341–346.
39. Rothermund, L., and M. Paul. 1998. Hypertension and the renin-angiotensin system-evidence from genetic and transgenic studies. Basic Res. Cardiol. 93 (Suppl. 2): 1–6.
40. Schmidt, S., J. Beige, M. Walla-Friedel, M. C. Michel, A. M. Sharma, and E. Ritz. 1997. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J. Hypertens. 15: 1385–1388.
41. Schork, N. J., J. E. Krieger, M. R. Trolliet, K. G. Franchini, G. Koike, E. M. Krieger, et al. 1995. A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res. 5: 164–172.
42. Sechi, L. A., C. A. Griffin, G. Giacchetti, J.-P. Valentin, C. Llorens-Cortes, P. Corvol, et al. 1996. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28: 403–408.
43. Shokoji, T., A. Nishiyama, Y. Fujisawa, H. Hitomi, H. Kiyomoto, N. Takahashi, et al. 2003. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266–273.
44. Taylor, R. W., and D. M. Turnbull. 2005. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 6: 389–402.
45. Tigerstedt, R., and P. Q. Bergman. 1898. Niere und Kreislauf1. Skand. Arch. Physiol. 8: 223–271.
46. Tomino, Y., Y. Makita, T. Shike, T. Gohda, M. Haneda, R. Kikkawa, et al. 1999. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 82: 139–144.
47. Wallace, D. C. 1999. Mitochondrial diseases in man and mouse. Science 283: 1482–1488.
48. Weir, M. R., and V. J. Dzau. 1999. The renin-angiotensinaldosterone system: a specific target for hypertension management. Am. J. Hypertens. 12: 205S–213S.
49. Wilson, F. H., A. Hariri, A. Farhi, H. Zhao, K. F. Petersen, H. R. Toka, et al. 2004. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306: 1190–1194.
50. Zhu, X., C. A. McKenzie, T. Forrester, D. A. Nickerson, U. Broeckel, H. Schunkert, et al. 2000. Localization of a small genomic region associated with elevated ACE. Am. J. Hum. Genet. 67: 1144–1153.